×
App Icon
The Standard e-Paper
Informed Minds Prefer The Standard
★★★★ - on Play Store
Download Now

FDA approves RSV vaccine for moms-to-be to guard their newborns

Vocalize Pre-Player Loader

Audio By Vocalize

US regulators on Aug 21, 2023 approved the first RSV vaccine for pregnant women so their babies will be born with protection against the respiratory infection. [AP Photo]

US regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with protection against the respiratory infection.

RSV is notorious for filling hospitals with wheezing babies every fall and winter. The Food and Drug Administration cleared Pfizer's maternal vaccination to guard against a severe case of RSV when babies are most vulnerable - from birth through 6 months of age.

Get Full Access for Ksh299/Week.
Uncover the stories others won’t tell. Subscribe now for exclusive access
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in
Football
Title-hungry Leopards seek to bounce back to winning ways
Golf
Magical Kenya Open: Jastas Madoya reveals what fuels his passion for golf
Olympics
NOC-K signs strategic MoU with Japanese Olympic Committee
Unique Sports
Youthful Kinoti Kiara crowned African fencing champion